Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Drug Discovery Outsourcing Market


4. Market Overview

4.1. Definition

4.2. Market Indicators

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

4.5. Global Drug Discovery Outsourcing Market Outlook


5. Key Insights

5.1. Key Mergers & Acquisition

5.2. Technological Advancements in Drug Discovery

5.3. Drug Discovery Process – an Overview

5.4. COVID-19 Pandemics Impact on Drug Discovery Outsourcing Industry

5.5. Overview of Companies outsourcing to CROs

5.6. Overview: Integrated Drug Discovery (IDD) outsourcing- trends, competition, business models preferred, type of projects outsourced


6. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Service Type

6.1. Introduction

6.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type

6.3. Global Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

6.3.1. Biological Services

6.3.2. Chemical Services

6.3.3. Lead Identification & Screening

6.3.4. Lead Optimization

6.3.5. Others

6.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type


7. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Drug Type

7.1. Introduction

7.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type

7.3. Global Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

7.3.1. Small Molecules

7.3.2. Large Molecules

7.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type


8. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Therapeutic Area

8.1. Introduction

8.2. Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area

8.3. Global Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

8.3.1. Respiratory System

8.3.2. Anti-infective

8.3.3. Oncology

8.3.4. Cardiovascular

8.3.5. Gastrointestinal

8.3.6. Central Nervous System

8.3.7. Immunomodulation

8.3.8. Others

8.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area


9. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Region

9.1. Regional Outlook

9.2. Introduction

9.3. Global Drug Discovery Outsourcing Market Value Forecast, by Region

9.3.1. North America

9.3.2. Europe

9.3.3. Asia Pacific

9.3.4. Latin America

9.3.5. Middle East & Africa

9.4. Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region


10. North America Drug Discovery Outsourcing Market Analysis and Forecast

10.1. Key Findings

10.2. North America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

10.2.1. Biological Services

10.2.2. Chemical Services

10.2.3. Lead Identification & Screening

10.2.4. Lead Optimization

10.2.5. Others

10.3. North America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

10.3.1. Small Molecules

10.3.2. Large Molecules

10.4. North America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

10.4.1. Respiratory System

10.4.2. Anti-infective

10.4.3. Oncology

10.4.4. Cardiovascular

10.4.5. Gastrointestinal

10.4.6. Central Nervous System

10.4.7. Immunomodulation

10.4.8. Others

10.5. North America Drug Discovery Outsourcing Market Value Forecast, by Country, 2018–2030

10.5.1. U.S.

10.5.2. Canada

10.6. North America Drug Discovery Outsourcing Market Attractiveness Analysis

10.6.1. By Service Type

10.6.2. By Drug Type

10.6.3. By Therapeutic Area

10.6.4. By Country


11. Europe Drug Discovery Outsourcing Market Analysis and Forecast

11.1. Key Findings

11.2. Europe Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

11.2.1. Biological Services

11.2.2. Chemical Services

11.2.3. Lead Identification & Screening

11.2.4. Lead Optimization

11.2.5. Others

11.3. Europe Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

11.3.1. Small Molecules

11.3.2. Large Molecules

11.4. Europe Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

11.4.1. Respiratory System

11.4.2. Anti-infective

11.4.3. Oncology

11.4.4. Cardiovascular

11.4.5. Gastrointestinal

11.4.6. Central Nervous System

11.4.7. Immunomodulation

11.4.8. Others

11.5. Europe Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

11.5.1. U.K.

11.5.2. Germany

11.5.3. France

11.5.4. Italy

11.5.5. Spain

11.5.6. Rest of Europe

11.6. Europe Drug Discovery Outsourcing Market Attractiveness Analysis

11.6.1. By Service Type

11.6.2. By Drug Type

11.6.3. By Therapeutic Area

11.6.4. By Country/Sub-region

12. Asia Pacific Drug Discovery Outsourcing Market Analysis and Forecast

12.1. Key Findings

1.1. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

12.1.1. Biological Services

12.1.2. Chemical Services

12.1.3. Lead Identification & Screening

12.1.4. Lead Optimization

12.1.5. Others

12.2. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

12.2.1. Small Molecules

12.2.2. Large Molecules

12.3. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

12.3.1. Respiratory System

12.3.2. Anti-infective

12.3.3. Oncology

12.3.4. Cardiovascular

12.3.5. Gastrointestinal

12.3.6. Central Nervous System

12.3.7. Immunomodulation

12.3.8. Others

12.4. Asia Pacific Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

12.4.1. China

12.4.2. India

12.4.3. Japan

12.4.4. Australia & New Zealand

12.4.5. Rest of Asia Pacific

12.5. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis

12.5.1. By Service Type

12.5.2. By Drug Type

12.5.3. By Therapeutic Area

12.5.4. By Country/Sub-region

13. Latin America Drug Discovery Outsourcing Market Analysis and Forecast

13.1. Key Findings

13.2. Latin America Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

13.2.1. Biological Services

13.2.2. Chemical Services

13.2.3. Lead Identification & Screening

13.2.4. Lead Optimization

13.2.5. Others

13.3. Latin America Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

13.3.1. Small Molecules

13.3.2. Large Molecules

13.4. Latin America Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

13.4.1. Respiratory System

13.4.2. Anti-infective

13.4.3. Oncology

13.4.4. Cardiovascular

13.4.5. Gastrointestinal

13.4.6. Central Nervous System

13.4.7. Immunomodulation

13.4.8. Others

13.5. Latin America Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Drug Discovery Outsourcing Market Attractiveness Analysis

13.6.1. By Service Type

13.6.2. By Drug Type

13.6.3. By Therapeutic Area

13.6.4. By Country/Sub-region


14. Middle East & Africa Drug Discovery Outsourcing Market Analysis and Forecast

14.1. Key Findings

14.2. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Service Type, 2018–2030

14.2.1. Biological Services

14.2.2. Chemical Services

14.2.3. Lead Identification & Screening

14.2.4. Lead Optimization

14.2.5. Others

14.3. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Drug Type, 2018–2030

14.3.1. Small Molecules

14.3.2. Large Molecules

14.4. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Therapeutic Area, 2018–2030

14.4.1. Respiratory System

14.4.2. Anti-infective

14.4.3. Oncology

14.4.4. Cardiovascular

14.4.5. Gastrointestinal

14.4.6. Central Nervous System

14.4.7. Immunomodulation

14.4.8. Others

14.5. Middle East & Africa Drug Discovery Outsourcing Market Value Forecast, by Country/Sub-region, 2018–2030

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis

14.6.1. By Service Type

14.6.2. By Drug Type

14.6.3. By Therapeutic Area

14.6.4. By Country/Sub-region


15. Competition Landscape

15.1. Market Player - Competition Matrix (by tier and size of companies)

15.2. Market Share Analysis, by Company, 2019

15.3. Company Profiles

15.3.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.1.2. Financial Overview

15.3.1.3. Product Portfolio

15.3.1.4. Strategic Overview

15.3.1.5. SWOT Analysis

15.3.2. WuXi AppTec Co., Ltd.

15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.2.2. Financial Overview

15.3.2.3. Product Portfolio

15.3.2.4. Strategic Overview

15.3.2.5. SWOT Analysis

15.3.3. Albany Molecular Research Inc. (AMRI)

15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.3.2. Financial Overview

15.3.3.3. Product Portfolio

15.3.3.4. Strategic Overview

15.3.3.5. SWOT Analysis

15.3.4. GVK Biosciences Private Limited

15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.4.2. Financial Overview

15.3.4.3. Product Portfolio

15.3.4.4. Strategic Overview

15.3.4.5. SWOT Analysis

15.3.5. Sygnature Discovery

15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.5.2. Financial Overview

15.3.5.3. Product Portfolio

15.3.5.4. Strategic Overview

15.3.5.5. SWOT Analysis

15.3.6. Pharmaron Beijing Co., Ltd.

15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.6.2. Financial Overview

15.3.6.3. Product Portfolio

15.3.6.4. Strategic Overview

15.3.6.5. SWOT Analysis

15.3.7. WuXi Biologics (Cayman), Inc.

15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.7.2. Financial Overview

15.3.7.3. Product Portfolio

15.3.7.4. Strategic Overview

15.3.7.5. SWOT Analysis

15.3.8. Domainex Ltd.

15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.8.2. Financial Overview

15.3.8.3. Product Portfolio

15.3.8.4. Strategic Overview

15.3.8.5. SWOT Analysis

15.3.9. Thermo Fisher Scientific, Inc.

15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.9.2. Financial Overview

15.3.9.3. Product Portfolio

15.3.9.4. Strategic Overview

15.3.9.5. SWOT Analysis

15.3.10. Jubilant Biosys Ltd.

15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.10.2. Financial Overview

15.3.10.3. Product Portfolio

15.3.10.4. Strategic Overview

15.3.10.5. SWOT Analysis

15.3.11. Evotec SE

15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.11.2. Financial Overview

15.3.11.3. Product Portfolio

15.3.11.4. Strategic Overview

15.3.11.5. SWOT Analysis

15.3.12. Eurofins Discovery

15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.12.2. Financial Overview

15.3.12.3. Product Portfolio

15.3.12.4. Strategic Overview

15.3.12.5. SWOT Analysis

15.3.13. GenScript Biotech Corporation

15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.13.2. Financial Overview

15.3.13.3. Product Portfolio

15.3.13.4. Strategic Overview

15.3.13.5. SWOT Analysis



List of Figures



Figure 01: Global Drug Discovery Outsourcing Market

Figure 02: Global Drug Discovery Outsourcing Market Size (US$ Mn) Forecast, 2018–2030

Figure 03: Global Drug Discovery Outsourcing market Value Share, by Service Type, 2020

Figure 04: Global Drug Discovery Outsourcing Market Value Share, by Drug Type, 2020

Figure 05: Global Drug Discovery Outsourcing Market Value Share, by Therapeutic Area, 2020

Figure 06: Global Drug Discovery Outsourcing Market Value Share, by Region, 2020

Figure 07: CRO Services Market – Key Mergers and Acquisitions

Figure 08: Technological Advancements in Drug Discovery

Figure 09: Drug Discovery & Development Process – an Overview

Figure 10: Drug Discovery Process – an Overview

Figure 11: IDD Trends

Figure 12: IDD Business Models

Figure 13: IDD- Types of Projects

Figure 14: Global Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 15: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 16: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biological Services, 2018–2030

Figure 17: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chemical Services, 2018–2030

Figure 18: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lead Identification & Screening, 2018–2030

Figure 19: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lead Optimization, 2018–2030

Figure 20: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030

Figure 21: Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 22: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type, 2020–2030

Figure 23: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Small Molecules, 2018–2030

Figure 24: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Large Molecules, 2018–2030

Figure 25: Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 26: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2020–2030

Figure 27: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Respiratory System, 2018–2030

Figure 28: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Anti-infective, 2018–2030

Figure 29: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oncology, 2018–2030

Figure 30: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiovascular, 2018–2030

Figure 31: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gastrointestinal, 2018–2030

Figure 32: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Central Nervous System, 2018–2030

Figure 33: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Immunomodulation, 2018–2030

Figure 34: Global Drug Discovery Outsourcing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030

Figure 35: Global Drug Discovery Outsourcing Market: Regional Outlook

Figure 36: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 37: Global Drug Discovery Outsourcing Market Value Share Analysis, by Region, 2019 and 2030

Figure 38: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region, 2020–2030

Figure 39: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 40: North America Drug Discovery Outsourcing Market Value Share Analysis, by Country, 2019 and 2030

Figure 41: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country, 2020–2030

Figure 42: North America Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 43: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 44: North America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 45: North America Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

Figure 46: North America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 47: North America Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

Figure 48: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 49: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 50: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 51: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 52: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 53: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 54: Europe Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

Figure 55: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 56: Europe Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

Figure 57: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 58: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 59: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 60: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 61: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 62: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 63: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Type, 2020–2030

Figure 64: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 65: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2020–2030

Figure 66: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 67: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 68: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 69: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 70: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 71: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 72: Latin America Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

Figure 73: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 74: Latin America Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

Figure 75: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, 2018–2030

Figure 76: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 77: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 78: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Service Type, 2019 and 2030

Figure 79: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Service Type, 2020–2030

Figure 80: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Drug Type, 2019 and 2030

Figure 81: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness, by Drug Type, 2020–2030

Figure 82: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2019 and 2030

Figure 83: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness, by Therapeutic Area, 2020–2030

Figure 84: Global Drug Discovery Outsourcing Market Analysis, by Top Company Ranking, 2019


List of Tables



Table 01: Companies entering into partnerships with CROs for drug discovery

Table 02: Integrated Drug Discovery – Key Players

Table 03: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 04: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 05: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

Table 06: Global Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 07: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 08: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 09: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 10: North America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

Table 11: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 12: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 13: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 14: Europe Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

Table 15: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 16: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 17: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 18: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

Table 19: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 20: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 21: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 22: Latin America Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030

Table 23: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 24: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 25: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Drug Type, 2018–2030

Table 26: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2018–2030